Lakefront Biotherapeutics (LKFT) EPS (Diluted) Growth (5y) (2019 - 2026)
Lakefront Biotherapeutics (LKFT) EPS (Diluted) Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.47% |
| Dec 31, 2025 | 14.92% |
| Sep 30, 2025 | 15.01% |
| Jun 30, 2025 | 58.94% |
| Mar 31, 2025 | 69.21% |
| Dec 31, 2024 | 14.87% |
| Sep 30, 2024 | -16.11% |
| Jun 30, 2024 | 16.54% |
| Mar 31, 2024 | 28.22% |
| Dec 31, 2023 | 52.79% |
| Sep 30, 2023 | 0.67% |
| Jun 30, 2023 | -32.62% |
| Mar 31, 2023 | 18.83% |
| Dec 31, 2022 | -32.75% |
| Sep 30, 2022 | 18.65% |
| Jun 30, 2022 | -18.33% |
| Mar 31, 2022 | 10.75% |
| Dec 31, 2021 | -20.19% |
| Jun 30, 2021 | 60.48% |
| Mar 31, 2021 | 168.21% |